Logo image
MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors
Journal article   Open access   Peer reviewed

MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors

Patrick L Ware, Anthony N Snow, Maya Gvalani, Mark J Pettenati and Shadi A Qasem
American journal of clinical pathology, Vol.141(3), pp.334-341
03/2014
DOI: 10.1309/AJCPLYU89XHSNHQO
PMID: 24515760
url
https://doi.org/10.1309/AJCPLYU89XHSNHQOView
Published (Version of record) Open Access

Abstract

MDM2 gene amplification is associated with well-differentiated (WDL) and dedifferentiated liposarcomas (DDL). Using fluorescent in situ hybridization (FISH), we sought to characterize various patterns of MDM2 amplification among the morphologic spectrum of liposarcoma. Forty-six cases of liposarcoma in various sites were examined and included 22 WDLs, 14 DLLs, and 10 negative control subjects. The MDM2 amplification ratio (MDM2/CEP12) was lower in WDL (10.2) compared with DDL (18.3) cases (P = .0000002). An amplification ratio of 16 showed optimal sensitivity (0.86) and specificity (0.96) as a cutoff point for progression to DDL. Borderline areas, defined as tumors with increased cellularity and atypia but with preserved lipomatous differentiation, showed a significantly higher MDM2 ratio (17.5; P = .0007) compared with WDL. Central (retroperitoneal and intra-abdominal) tumors also showed a significantly higher MDM2 ratio than peripheral ones (P = .02). Differences in MDM2 amplification profiles among liposarcomas could help further define and predict progression to high-grade neoplasia.
Proto-Oncogene Proteins c-mdm2 - genetics Humans Liposarcoma - pathology Middle Aged Liposarcoma - genetics Male Disease Progression DNA Copy Number Variations Cell Differentiation - genetics Aged, 80 and over Adult Female Aged Biomarkers, Tumor - genetics

Details

Metrics

Logo image